Opiant Pharmaceuticals Inc (OPNT)


Stock Price Forecast

March 2, 2023


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Opiant Pharmaceuticals Inc chart...

About the Company

Opiant Pharmaceuticals, Inc., the company that developed NARCAN® Nasal Spray, is building a leading franchise of new medicines to combat addictions and drug overdose.

Exchange

NASDAQ

Website

www.opiant.com

$22M

Total Revenue

38

Employees

$107M

Market Capitalization

-3.14

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $OPNT News

Pharmaceutical companies behind weight-loss drugs are slimming down a new target: The Magnificent 7

on MSN ago, source:

In today's big story, we're looking at pharma companies' surging stocks and threatening tech darlings thanks to their ...

Buy Rating Justified for Olema Pharmaceuticals Amidst Promising Trial Results and Significant Market Opportunity

6d ago, source:

Analyst Naureen Quibria of Capital One Financial reiterated a Buy rating on Olema Pharmaceuticals (OLMA – Research Report), with a price ...

TD Cowen Keeps Their Buy Rating on Ionis Pharmaceuticals (IONS)

12d ago, source:

In a report released today, Yaron Werber from TD Cowen maintained a Buy rating on Ionis Pharmaceuticals (IONS – Research Report). The ...

Marinus Pharmaceuticals: Q4 Earnings Snapshot

13d ago, source:

The Radnor, Pennsylvania-based company said it had a loss of 74 cents per share. The results did not meet Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment ...

EyePoint Pharmaceuticals: Q4 Earnings Snapshot

11d ago, source:

WATERTOWN, Mass. (AP) — WATERTOWN, Mass. (AP) — EyePoint Pharmaceuticals (EYPT) on Thursday reported a loss of $14.1 million in its fourth quarter. On a per-share basis, the Watertown, ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...